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Background
SNP genotyping microarrays may be used to detect
regions of loss-of-heterozygosity (LOH). Genotype array
data are collected for tumor tissue and germline tissue
samples from each subject. For each subject, an initial call
of LOH or non-LOH is generated for each marker via
straightforward comparison of the genotype call across
each tissue sample pair [1]. The genotype calls are gener-
ated with some error. Therefore, statistical models are
used to analyze the pattern of LOH calls to infer regions of
LOH for each subject [1].
Materials and methods
We propose call-based segmentation analysis (CBSA) as a
permutation-based method to infer regions of LOH from
this type of data. Chromosome endpoints and the posi-
tions of markers with initial LOH calls are used to divide
the genomes of study subjects into a series of distinct seg-
ments that are indexed by subject and location. The size of
each segment is measured by the number of non-LOH
calls it contains.
CBSA performs a permutation test to determine whether a
segment has significantly fewer non-LOH calls than
expected by chance. Permuting the assignment of initial
LOH calls to subject and genomic position generates an
empirical null distribution of segment size for computing
p-values. In practice, p-values may be computed with a
very accurate analytical approximation of the permuta-
tion distribution [2].
Next, the false discovery rate (FDR) is estimated with a
robust method [3]. Finally, each segment defined by the
observed positions of LOH calls has a size, p-value, and
FDR estimate associated with it. Each segment with an
FDR estimate below a selected threshold is inferred to be
a segment of LOH. Mathematical proofs establish that the
FDR estimate is conservative, i.e., the estimated FDR is
expected to be greater than the actual FDR [3].
Results
In our study of LOH in secondary leukemia [4], we
applied CBSA with an estimated FDR of 10%. CBSA
showed similar or greater sensitivity than dChip SNP [1]
to detect LOH on each chromosome with one-copy loss
according to cytogenetics [5]. Additionally, CBSA was
robust against poor quality. After exclusion of two sub-
jects with poor quality data, CBSA inferences were con-
cordant with original CBSA inferences for the remaining
eleven subjects at 99.6% of all markers.
Conclusion
CBSA is a practically useful method for detecting LOH.
CBSA is conceptually simple, computationally efficient,
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statistically sound, and robust. Furthermore, CBSA may
be a more powerful method than dChip SNP for some
studies.
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